Chapter 34: Managing Inflammatory Rheumatic Disorders
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Managing Inflammatory Rheumatic Disorders nursing chapter details the etiology, assessment, and therapeutic management of diverse inflammatory rheumatic disorders, which are systemic conditions characterized by inflammation, autoimmunity, and degeneration affecting the joints, muscles, and soft tissues of the body. These disorders, which are significantly more common in women, typically manifest as chronic pain, stiffness, and arthritis, often leading to limitations in daily functioning, fatigue, and potentially severe systemic effects like organ failure. The central pathogenesis involves the immune system mistakenly recognizing the body's own tissue as a foreign antigen. This triggers a complex inflammatory response mediated by B and T lymphocytes, resulting in the formation and deposition of immune complexes in tissues. Chronic inflammation causes proliferation of synovial tissue known as pannus formation, which destroys cartilage and erodes bone, leading to permanent joint damage and disability. Assessment includes a detailed health history, a physical examination focusing on musculoskeletal and extra-articular manifestations, and a functional assessment evaluating mobility and self-care abilities. Diagnosis utilizes key serological markers, including Antinuclear Antibody (ANA), Rheumatoid Factor (RF), C-Reactive Protein (CRP), and Erythrocyte Sedimentation Rate (ESR), along with various imaging studies. Treatment involves a shared decision-making model and relies heavily on Disease-Modifying Antirheumatic Drugs (DMARDs)—both nonbiologic (such as methotrexate, often the first-line agent) and biologic (specifically targeting inflammatory cytokines like TNF-alpha or interleukins)—to suppress the autoimmune response and alter disease progression. Symptom relief is achieved using nonsteroidal anti-inflammatory drugs (NSAIDs) and nonpharmacologic strategies, including specialized heat applications (paraffin baths), assistive devices, and individualized exercise programs (ROM, isometric, dynamic, and pool exercises). The chapter explores specific diseases such as Rheumatoid Arthritis (RA), a symmetric polyarticular disorder prone to extra-articular features like nodules and Raynaud’s phenomenon; Systemic Lupus Erythematosus (SLE), a multisystem disease involving the kidneys (lupus nephritis), heart (pericarditis), and CNS, necessitating management of flares and strict avoidance of sun exposure; Sjögren’s Syndrome, characterized by sicca symptoms (dry eyes and mouth); Scleroderma (Systemic Sclerosis), identified by collagen overproduction leading to hard, rigid skin and organ damage, often presenting as CREST syndrome; Gout, the most prevalent inflammatory arthritis caused by hyperuricemia and managed by xanthine oxidase inhibitors and dietary changes; and Fibromyalgia, a chronic pain syndrome believed to involve neurogenic amplification of pain signals. Nursing management is centered on patient education for self-management, promoting restorative sleep, managing chronic fatigue, and ensuring medication adherence while monitoring for systemic complications and side effects, especially considering unique challenges in older adult populations.